Moore Paul Andrew's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jan 8, 2024
- Accession no.
- 0000950170-24-003076
- Filed
- Jan 8, 2024
- Trade date
- Jan 5-8, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $105.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moore Paul AndrewCIK 0001938192 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Common Stock | MOption exerciseAcquired | +17,166 | $0.00 | $0 | 17,166 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −7,460 | $10.65 | −$79,449 | 9,706 | Direct | |
| Jan 8, 2024 | Common Stock | SSaleDisposed | −2,339 | $11.22 | −$26,243.58 | 7,367 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Common Stock | MOption exerciseDisposed | −17,166 | $0.00 | $0 | 34,334 | Direct | |
| Jan 5, 2024 | Common Stock | AGrant or awardAcquired | +90,000 | $0.00 | $0 | 90,000 | Direct | |
| Jan 5, 2024 | Common Stock | AGrant or awardAcquired | +60,000 | $0.00 | $0 | 60,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.